# STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism

> **NCT04727437** · PHASE3 · UNKNOWN · sponsor: **University of Birmingham** · enrollment: 1466 (estimated)

## Conditions studied

- Subsegmental Pulmonary Embolism Nos

## Interventions

- **OTHER:** No treatment
- **DRUG:** Warfarin
- **DRUG:** direct oral anticoagulants
- **DRUG:** Low molecular weight heparin

## Key facts

- **NCT ID:** NCT04727437
- **Lead sponsor:** University of Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-08
- **Primary completion:** 2023-07
- **Final completion:** 2024-05
- **Target enrollment:** 1466 (ESTIMATED)
- **Last updated:** 2021-09-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04727437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04727437, "STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04727437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*